Mounjaro is approved for type 2 diabetes management, while Zepbound is approved for chronic weight management in adults with obesity or in those overweight with a weight-related health condition, such as high blood pressure, high cholesterol, or type 2 diabetes
Furthermore, Coleman and Lee (2004) suggested that with elevated physiological carnitine levels in the liver, very-low-density lipoprotein (LDL), triglyceride, and cholesterol secretion rates were lower
But how exactly do these drugs work
[5] [11] Clinical trials have demonstrated significant weight loss with these medicationstypically 15% with semaglutide 2.4mg (Wegovy) and 5-8% with liraglutide 3.0mg (Saxenda) over 68 weekswhen used alongside dietary changes and physical activity advice
Moreover, the endogenous or exogenous risk factors that influence mucosal melanocyte transformation, as well as the identity of MM precursor lesions, are ambiguous